Discover 2,409 paid clinical trials in Naperville, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,409
Active & Responsive
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
for
Treatment Resistant Depression
Location: Chicago IL, Saint Charles MO, Columbus OH,
Sponsor: atai Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT06524830
Phase 2, Recruiting
Active & Responsive
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
for
Opioid Use Disorder, Opioid Use Disorder, Moderate,
Location: Chicago IL, Cape Girardeau MO, Huntington WV,
Sponsor: T. John Winhusen, PhD
Sex: All
Age: 18+
Code: NCT06651177
Phase 2, Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
for
Triple Negative Breast Neoplasms
Location: Chicago IL, Grand Rapids MI, Nashville TN, Toronto,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06841354
Phase 3, Recruiting
Active & Responsive
Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)
for
Acute Myeloid Leukemia, Relapsed, Adult,
Location: Chicago IL
Sponsor: University of Illinois at Chicago
Sex: All
Age: 18 - 65
Code: NCT06802315
Phase 2, Recruiting
Active & Responsive
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
for
Prostate Cancer, Prostatic Neoplasms
Location: Chicago IL, Milwaukee WI, Madison WI, Grand Rapids MI,
Sponsor: Merck Sharp & Dohme LLC
Sex: Male
Age: 18+
Code: NCT06925737
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Location: Chicago IL, Ann Arbor MI, Columbus OH, Cleveland OH,
Sponsor: University of Michigan
Sex: All
Age: 0 - 70+
Code: NCT01209000
Recruiting
Active & Responsive
Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin
for
Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0), Albuminuria
Location: Chicago IL
Sponsor: University of Illinois at Chicago
Sex: All
Age: 18 - 60
Code: NCT07175051
Phase 2, Recruiting
Active & Responsive
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
for
Sickle Cell Disease
Location: Chicago IL, Louisville KY, Birmingham AL,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 12 - 70+
Code: NCT06439082
Phase 3, Recruiting
Active & Responsive
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Location: Chicago IL, Indianapolis IN, Hannibal MO, Ann Arbor MI,
Sponsor: Tempus AI
Sex: All
Age: 18+
Code: NCT06911632
Recruiting
Active & Responsive
Optimization of NIBS for Treatment of Addiction
for
Opioid-use Disorder, Chronic Pain
Location: Hinsdale IL, Cleveland OH, Cambridge MA
Sponsor: Case Western Reserve University
Sex: All
Age: 18 - 70+
Code: NCT04379115
Recruiting
Active & Responsive
Topical Probiotic Sinus Irrigations for Treating Chronic Sinusitis
for
Chronic Rhinosinusitis (Diagnosis)
Location: Chicago IL
Sponsor: University of Illinois at Chicago
Sex: All
Age: 18+
Code: NCT05427695
Phase 2, Recruiting
Active & Responsive
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
for
Diabetes Mellitus, Type 1, Hypoglycemia,
Location: Chicago IL
Sponsor: Otsuka Pharmaceutical Factory, Inc.
Sex: All
Age: 35 - 70
Code: NCT06575426
Phase 1, Phase 2, Recruiting
Active & Responsive
Safety and Efficacy Study of ICXP007 With Compression Bandaging for the Treatment of Non-Infected Venous Leg Ulcers
for
Leg Ulcer
Location: Niles IL, North Chicago IL, Springfield IL, Columbus OH,
Sponsor: Intercytex
Sex: All
Age: 18+
Code: NCT00232973
Phase 3, Recruiting
Active & Responsive
Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
for
Hemophilia A
Location: Chicago IL, Indianapolis IN, Cincinnati OH, Detroit MI,
Sponsor: Wayne State University
Sex: All
Age: 6 - 19
Code: NCT05022459
Recruiting
Active & Responsive
Community-based Approach to Lowering Stress Through Mindfulness
for
Depression, Hypertension
Location: Chicago IL
Sponsor: Northwestern University
Sex: All
Age: 18+
Code: NCT06987799
Recruiting
Active & Responsive
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
for
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Location: Chicago IL, Detroit MI, Columbus OH, Kansas City MO,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07266831
Phase 2, Phase 3, Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
for
Breast Neoplasms
Location: Chicago IL, Madison WI, St Louis MO, Detroit MI,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06312176
Phase 3, Recruiting
Active & Responsive
RemI for Post-Bariatric Surgery Weight Regain
for
Obesity, Bariatric Surgery Candidate
Location: Chicago IL, Philadelphia PA
Sponsor: Temple University
Sex: All
Age: 18 - 70
Code: NCT06292936
Recruiting
Active & Responsive
A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease
for
Degenerative Disc Disease
Location: Chicago IL, Carmel IN, St Louis MO, Rochester MN,
Sponsor: DiscGenics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07254806
Phase 3, Recruiting
Active & Responsive
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: Chicago IL, Madison WI, Indianapolis IN, Ann Arbor MI,